A Study to Assess if DNA Can Be Detect in the Liquid Samples from the Upper GI Tract

Overview

About this study

The purpose of this study is to determine if microbiome DNA can be detected in the juice from the upper GI tract and that of the clinical residual specimens from patients who have or will experience an endoscopic ultrasound with sampling as part of their clinical care.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • 18 years of age or older
  • Endoscopic ultrasound performed to evaluate standard clinical indications that are independent of this study

Exclusion Criteria: 

  • History of chemotherapy or radiation therapy
  • Use of antibiotics up to 2 weeks preceding endoscopic procedure

More information

Publications

Publications are currently not available
.
CLS-20304713

Mayo Clinic Footer